Immune Cell Engineering: Targeting Checkpoint Inhibitors

Related lectures (32)

Page 2 of 4

Covers immune responses to tumors, cancer therapy, and challenges in personalized cancer vaccines and combination therapies.

Explores the tumor microenvironment, stromal components, cell interactions, and the impact of inflammation on cancer promotion.

Explores the steps and phases of the adaptive immune response.

Explores experimental evidence supporting immunoediting of tumors and the use of immunotherapy to enhance antitumor immune responses.

Explores B cell activation, antibody production, isotype switching, and memory B cell formation in humoral immune responses.

Explores breakthroughs in cancer immunotherapy, including immune checkpoint blockade and adoptive T cell therapies.

Covers precision tumor recognition by T cells with combinatorial antigen-sensing circuits and the impact of vaccination on human health.

Explores the mechanisms and applications of cancer immunotherapies, including antibody-based treatments and genetically engineered T-cells.

Delves into immune selection, cancer evolution, neoantigen quality, fitness cost, tumor heterogeneity, and evolutionary predictions.

Explores immunoengineering techniques like flow cytometry and microengraving for capturing immune responses and live cell information.